Trevena Inc (TRVN)
1.69
-0.06
(-3.43%)
USD |
OTCM |
Nov 04, 16:00
Trevena Total Assets (Quarterly): 22.94M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.94M |
| March 31, 2024 | 31.14M |
| December 31, 2023 | 40.60M |
| September 30, 2023 | 45.13M |
| June 30, 2023 | 38.86M |
| March 31, 2023 | 38.29M |
| December 31, 2022 | 48.68M |
| September 30, 2022 | 51.02M |
| June 30, 2022 | 64.80M |
| March 31, 2022 | 64.42M |
| December 31, 2021 | 80.12M |
| September 30, 2021 | 91.65M |
| June 30, 2021 | 112.20M |
| March 31, 2021 | 118.50M |
| December 31, 2020 | 127.74M |
| September 30, 2020 | 122.56M |
| June 30, 2020 | 66.32M |
| March 31, 2020 | 39.05M |
| December 31, 2019 | 46.99M |
| September 30, 2019 | 56.77M |
| June 30, 2019 | 65.18M |
| March 31, 2019 | 71.89M |
| December 31, 2018 | 66.78M |
| Date | Value |
|---|---|
| September 30, 2018 | 76.11M |
| June 30, 2018 | 72.33M |
| March 31, 2018 | 68.64M |
| December 31, 2017 | 72.72M |
| September 30, 2017 | 84.24M |
| June 30, 2017 | 92.01M |
| March 31, 2017 | 103.14M |
| December 31, 2016 | 114.65M |
| September 30, 2016 | 122.13M |
| June 30, 2016 | 148.57M |
| March 31, 2016 | 166.91M |
| December 31, 2015 | 175.35M |
| September 30, 2015 | 170.67M |
| June 30, 2015 | 107.99M |
| March 31, 2015 | 103.20M |
| December 31, 2014 | 108.24M |
| September 30, 2014 | 73.96M |
| June 30, 2014 | 84.69M |
| March 31, 2014 | 95.16M |
| December 31, 2013 | 42.39M |
| September 30, 2013 | 50.45M |
| June 30, 2013 | 56.45M |
| December 31, 2012 | 8.088M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.94M
Minimum
Jun 2024
127.74M
Maximum
Dec 2020
65.84M
Average
51.02M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 216.19B |
| United Therapeutics Corp | 7.123B |
| Syndax Pharmaceuticals Inc | 476.95M |
| Arcus Biosciences Inc | 1.186B |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.90M |
| Shareholders Equity (Quarterly) | -18.96M |
| Debt to Equity Ratio | -1.663 |
| Current Ratio | 3.464 |
| Net Debt Paydown Yield | -77.67% |